Hepion Pharmaceuticals, Inc.
HEPA- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001583771
In the last 90 days, Hepion Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 1 institution reported holding it in 13F filings for Q2 2026, worth $0 in total; no superinvestor holds it.
Other share classesCTRVP
13F holders, Q3 2022
Institutional positions in Hepion Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −2 vs. Q2 2022
- Shares held
- 7.15M
- −261.0K (−3.5%) vs. Q2 2022
- Total value
- $3.61M
- −$630.7K (−14.9%) vs. Q2 2022
- New holders
- 5
- 6 more added
- Sold out
- 7
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HEPA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $0 |
| Q1 2026 | 1 | $0 |
| Q4 2025 | 1 | $0 |
| Q3 2025 | 1 | $0 |
| Q2 2025 | 4 | $1.39K |
| Q1 2025 | 16 | $419.7K |
| Q4 2024 | 22 | $215.4K |
| Q3 2024 | 22 | $338.2K |
| Q2 2024 | 24 | $863.9K |
| Q1 2024 | 25 | $1.77M |
| Q4 2023 | 24 | $2.42M |
| Q3 2023 | 24 | $4.00M |
| Q2 2023 | 23 | $5.43M |
| Q1 2023 | 32 | $5.60M |
| Q4 2022 | 32 | $2.20M |
| Q3 2022 | 32 | $3.61M |
| Q2 2022 | 34 | $4.24M |
| Q1 2022 | 38 | $9.74M |
| Q4 2021 | 43 | $9.00M |
| Q3 2021 | 42 | $11.9M |
| Q2 2021 | 49 | $21.3M |
| Q1 2021 | 45 | $14.7M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Hepion Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Bank of America Corp | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 506 | $0 | 0.00% | −4−0.8% | Reduced |
| Barclays PLC | 309 | $0 | 0.00% | 00.0% | Unchanged |
| Signaturefd, LLC | 2 | $0 | 0.00% | 00.0% | Unchanged |
| Harbor Investment Advisory, LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Capital Advisors, Ltd. LLC | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 485 | $0 | 0.00% | +485 | New |
| Benjamin F. Edwards & Company, Inc. | 1,001 | $1.00K | 0.00% | 00.0% | Unchanged |
| Federation des caisses Desjardins du Quebec | 3,500 | $1.77K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 10,800 | $5.00K | 0.00% | +10,800 | New |
| Cetera Investment Advisers | 11,273 | $6.00K | 0.00% | +11,273 | New |
| Morgan Stanley | 17,407 | $8.00K | 0.00% | −8,233−32.1% | Reduced |
| Tower Research Capital LLC (TRC) | 19,966 | $10.0K | 0.00% | +8,318+71.4% | Added |
| Citadel Advisors LLC | 21,561 | $11.0K | 0.00% | +21,561 | New |
| Group One Trading, L.P. | 26,236 | $13.0K | 0.00% | +700+2.7% | Added |
| Two Sigma Advisers, LP | 30,100 | $15.0K | 0.00% | −15,700−34.3% | Reduced |
| Charles Schwab Investment Management Inc | 31,535 | $16.0K | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 31,093 | $16.0K | 0.00% | +6,327+25.5% | Added |
| The PNC Financial Services Group, Inc. | 57,534 | $29.0K | 0.00% | 00.0% | Unchanged |
| McAdam, LLC | 62,169 | $31.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 67,802 | $34.0K | 0.00% | +44,867+195.6% | Added |
| Envestnet Asset Management Inc | 87,541 | $44.0K | 0.00% | +27,487+45.8% | Added |
| PVG Asset Management Corp | 107,915 | $54.5K | 0.21% | +107,915 | New |
| Northern Trust Corp | 132,059 | $67.0K | 0.00% | −1,205−0.9% | Reduced |
| Bank of New York Mellon Corp | 158,217 | $80.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 165,190 | $84.0K | 0.00% | +71,421+76.2% | Added |
| Renaissance Technologies LLC | 232,100 | $117.0K | 0.00% | −2,500−1.1% | Reduced |
| State Street Corp | 313,500 | $158.0K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 658,110 | $332.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 1,592,781 | $805.0K | 0.00% | −21,935−1.4% | Reduced |
| Vanguard Group Inc | 3,308,523 | $1.67M | 0.00% | 00.0% | Unchanged |
| IFP Advisors, Inc | 1 | – | – | 00.0% | Unchanged |
| Ikarian Capital, LLC | 0 | $0 | 0.00% | −410,189−100.0% | Sold out |
| Boothbay Fund Management, LLC | 0 | $0 | 0.00% | −45,108−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −40,445−100.0% | Sold out |
| Commonwealth Equity Services, LLC | 0 | $0 | 0.00% | −10,090−100.0% | Sold out |
| Amplius Wealth Advisors, LLC | 0 | $0 | 0.00% | −10,000−100.0% | Sold out |
| Geneos Wealth Management Inc. | 0 | $0 | 0.00% | −5,000−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −1,770−100.0% | Sold out |